6 evolution "https:" "https:" "https:" "https:" "https:" "https:" "The University of Manchester" positions at Center for Biologics Evaluation and Research (CBER) in United States
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago
on the development and validation of regulatory-relevant preclinical disease models to support the evaluation of gene therapies for rare neurological and neuromuscular disorders. Examples of potential projects
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Division of Plasma Protein Therapeutics (DPPT), Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA) in Silver Spring, Maryland. The...
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing
-
Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 2 hours ago
various stages of parasite development. This is a pioneering project that seeks to define the global post-transcriptional regulatory processes involved in parasite transmission. The results of these studies
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 2 hours ago
the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Project: This research project focuses on advancing the development and
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Project: You will participate in the development of novel quantitative approaches for benefit-risk analyses